Answers are grounded in this paper and cite their sources.
Background The placenta is sexually dimorphic: fetal sex shapes placental gene expression, growth and immunity. Public placental transcriptomes are increasingly reused to define gestational diabetes mellitus (GDM) signatures; whether fetal sex can be separated from maternal hyperglycemia and fetal overgrowth in these datasets has not been tested. Methods Six public cohorts (bulk and single-cell RNA-seq, spatial transcriptomics, expression array) were reanalyzed under an a priori-defined Plan–Do–Check–Act audit (C1–C17). Fetal sex was inferred per sample from seven Y-linked markers and XIST; sex-linked, copy-number and segmental-duplication genes were excluded; X enrichment was tested rather than assumed; signatures were tested for cross-cohort transfer; compartment mapping used within-sample correlations in four control villi; cis-Mendelian randomization was exploratory. Results In the only cohort with a growth contrast, sex separated the groups completely: both cases were female (Y-marker counts 24 and 12; XIST 14,129 and 18,191), whereas the control and the insulin-treated sample were male (Y 29,124 and 26,300). Twelve of the 20 largest uncorrected effects were Y-linked or copy-number artifacts. Under the corrected specification the overgrowth-associated set fell from 2,930 to 1,872 genes, and the growth-discordant set (1,014 mapped genes) was unstable across leave-one-out (1,376 vs 665; Jaccard 0.55–0.70). The overgrowth-associated set showed no X enrichment (1.02×, P = 0.89). Transferability was limited: subtype signatures did not transfer to an independent hyperglycemia cohort (rho − 0.03 to − 0.06) and replicated only weakly on an array (rho 0.105–0.132); the shared-direction set reversed in both external cohorts; mitochondrial-RNA down-regulation tracked preeclampsia (13/13) rather than GDM (8/13). In control villi the overgrowth-associated set localized to cytotrophoblast (r = 0.42) and the growth-discordant set to fibroblast (r = 0.40). Conclusions In public placental transcriptomes fetal sex is not a covariate that can be adjusted away: it is confounded with, and in the critical arm identical to, the exposure contrast. GDM signature and sex-difference claims derived from single-sex arms are non-identifiable. Cohorts should report fetal sex and growth per sample, balance sex within arm, and pre-specify sex-aware filters.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: